[Oncologic aspects of estrogen-replacement therapy].
The following problems are discussed in this short review: (1) General issues (drugs, dosage, indications); (2) Risk of cancer development in women receiving estrogen-replacement therapy (ERT); (3) Attempts to extend ERT to breast and endometrial carcinoma patients; (4) Difficulties involved, doubts and perspectives.
Berstein
L M
LM
Prof. N.N. Petrov Research Institute Oncology, Health Ministry of the RF, St. Petersburg.
D001943:Breast Neoplasms / Q000139:chemically induced; D016889:Endometrial Neoplasms / Q000139:chemically induced; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced* / Q000517:prevention & control*; D011372:Progestins / Q000008:administration & dosage; D012306:Risk; D014594:Uterine Neoplasms / Q000517:prevention & control
D004967:Estrogens; D011372:Progestins